Results
|
2481.
|
|
|
2482.
|
|
|
2483.
|
|
|
2484.
|
|
|
2485.
|
|
|
2486.
|
|
|
2487.
|
|
|
2488.
|
|
|
2489.
|
|
|
2490.
|
|
|
2491.
|
|
|
2492.
|
|
|
2493.
|
|
|
2494.
|
|
|
2495.
|
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. [electronic resource] by
- Sax, Paul E
- DeJesus, Edwin
- Mills, Anthony
- Zolopa, Andrew
- Cohen, Calvin
- Wohl, David
- Gallant, Joel E
- Liu, Hui C
- Zhong, Lijie
- Yale, Kitty
- White, Kirsten
- Kearney, Brian P
- Szwarcberg, Javier
- Quirk, Erin
- Cheng, Andrew K
Producer: 20120801
In:
Lancet (London, England) vol. 379
Availability: No items available.
|
|
2496.
|
|
|
2497.
|
|
|
2498.
|
|
|
2499.
|
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1. [electronic resource] by
- McCormick, Adele L
- Parry, Chris M
- Crombe, Anne
- Goodall, Ruth L
- Gupta, Ravindra K
- Kaleebu, Pontiano
- Kityo, Cissy
- Chirara, Michael
- Towers, Greg J
- Pillay, Deenan
Producer: 20110715
In:
Antimicrobial agents and chemotherapy vol. 55
Availability: No items available.
|
|
2500.
|
|